{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T20:02:34Z","timestamp":1760385754104,"version":"3.37.3"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,1,21]],"date-time":"2020-01-21T00:00:00Z","timestamp":1579564800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,21]],"date-time":"2020-01-21T00:00:00Z","timestamp":1579564800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Spinal Cord"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1038\/s41393-020-0416-8","type":"journal-article","created":{"date-parts":[[2020,1,21]],"date-time":"2020-01-21T16:02:53Z","timestamp":1579622573000},"page":"705-710","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Use of oral third generation cephalosporins and quinolones and occurrence of antibiotic-resistant strains in the neurogenic bladder (NB) outpatient setting: a retrospective chart audit"],"prefix":"10.1038","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4508-2671","authenticated-orcid":false,"given":"Koichi","family":"Kitagawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsumi","family":"Shigemura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Nomi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nozomi","family":"Takami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Fujisawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,21]]},"reference":[{"key":"416_CR1","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1377\/hlthaff.2017.1153","volume":"37","author":"KE Thorpe","year":"2018","unstructured":"Thorpe KE, Joski P, Johnston KJ. Antibiotic-resistant infection treatment costs have doubled since 2002, now exceeding $2 billion annually. Health Aff. 2018;37:662\u20139.","journal-title":"Health Aff."},{"key":"416_CR2","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/S1473-3099(16)00065-7","volume":"16","author":"EC Schuts","year":"2016","unstructured":"Schuts EC, Hulscher MEJL, Mouton JW, Verduin CM, Stuart JWTC, Overdiek HWPM, et al. Current evidence on hospital antimicrobial stewardship objectives: a systematic review and meta-analysis. Lancet Infect Dis. 2016;16:847\u201356.","journal-title":"Lancet Infect Dis."},{"key":"416_CR3","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jinf.2014.05.005","volume":"69","author":"KK Perez","year":"2014","unstructured":"Perez KK, Olsen RJ, Musick WL, Cernoch PL, Davis JR, Peterson LE, et al. Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremia. J Infect. 2014;69:216\u201325.","journal-title":"J Infect."},{"key":"416_CR4","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.jiac.2018.11.006","volume":"25","author":"Y Moriyama","year":"2019","unstructured":"Moriyama Y, Ishikane M, Hayakawa K, Yamamoto K, Akazawa T, Sugiki Y, et al. Comparison of knowledge to antimicrobial stewardship institution policies targeting Staphylococcus aureus bacteremia and candidemia between medical doctors and pharmacists in an academic teaching hospital in Japan. J Infect Chemother. 2019;25:396\u20139.","journal-title":"J Infect Chemother"},{"key":"416_CR5","doi-asserted-by":"publisher","first-page":"4274","DOI":"10.3390\/ijerph10094274","volume":"10","author":"CR Lee","year":"2013","unstructured":"Lee CR, Cho IH, Jeong BC, Lee SH. Strategies to minimize antibiotic resistance. Int J Environ Res Public Health. 2013;10:4274\u2013305.","journal-title":"Int J Environ Res Public Health"},{"key":"416_CR6","unstructured":"Bonkat G, Pickard R, Bartoletti R, Cai T, Bruy\u00e8re F, Geerlings SE, et al. EAU guideline urological infection. Catheter associated UTI. 2018. p. 22. https:\/\/uroweb.org\/wp-content\/uploads\/EAU-Guidelines-on-Urological-Infections-2018-large-text.pdf."},{"key":"416_CR7","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s15010-017-1099-8","volume":"46","author":"T Kimura","year":"2018","unstructured":"Kimura T, Uda A, Sakaue T, Yamashita K, Nishioka T, Nishimura S, et al. Long-term efficacy of comprehensive multidisciplinary antibiotic stewardship programs centered on weekly prospective audit and feedback. Infection. 2018;46:215\u201324.","journal-title":"Infection."},{"key":"416_CR8","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1080\/1120009X.2017.1376817","volume":"30","author":"K Shigemura","year":"2018","unstructured":"Shigemura K, Kitagawa K, Osawa K, Yamamichi F, Tokimatsu I, Nomi M, et al. Comparison of antibiotics use, urinary tract infection (UTI)-causative bacteria and their antibiotic susceptibilities among 4 hospitals with different backgrounds and regions in Japan. J Chemother. 2018;30:31\u20136.","journal-title":"J Chemother."},{"key":"416_CR9","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1093\/clinids\/10.4.867","volume":"10","author":"V Jarlier","year":"1988","unstructured":"Jarlier V, Nicolas MH, Fournier G, Philippon A. Extended broad-spectrum bet alactamases conferring transferable resistance to newer bet alactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis. 1988;10:867\u201378.","journal-title":"Rev Infect Dis"},{"key":"416_CR10","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"AP Magiorakos","year":"2012","unstructured":"Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18:268\u201381.","journal-title":"Clin Microbiol Infect"},{"key":"416_CR11","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.cmi.2017.08.026","volume":"23","author":"OJ Dyar","year":"2017","unstructured":"Dyar OJ, Huttner B, Schouten J, Pulcini C. ESGAP (ESCMID Study Group for Antimicrobial stewardship). What is antimicrobial stewardship? Clin Microbiol Infect. 2017;23:793\u20138.","journal-title":"Clin Microbiol Infect"},{"key":"416_CR12","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.1016\/j.ajic.2013.11.018","volume":"42","author":"K Takaba","year":"2014","unstructured":"Takaba K, Shigemura K, Osawa K, Nomi M, Fujisawa M, Arakawa S. Emergence of extended-spectrum \u03b2-lactamase-producing Escherichia coli in catheter-associated urinary tract infection in neurogenic bladder patients. Am J Infect Control. 2014;42:e29\u201331.","journal-title":"Am J Infect Control"},{"key":"416_CR13","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1007\/s00134-014-3485-3","volume":"40","author":"JF Timsit","year":"2014","unstructured":"Timsit JF, Harbarth S, Carlet J. De-escalation as a potential way of reducing antibiotic use and antimicrobial resistance in ICU. Intensive Care Med. 2014;40:1580\u201382.","journal-title":"Intensive Care Med"},{"key":"416_CR14","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1016\/j.ajic.2016.04.239","volume":"44","author":"JF Carbo","year":"2016","unstructured":"Carbo JF, Ruh CA, Kurtzhalts KE, Ott MC, Sellick JA, Mergenhagen KA. Male veterans with complicated urinary tract infections: influence of a patient-centered antimicrobial stewardship program. Am J Infect Control. 2016;44:1549\u201353.","journal-title":"Am J Infect Control"},{"key":"416_CR15","first-page":"1308","volume":"60","author":"LA Hicks","year":"2015","unstructured":"Hicks LA, Bartoces MG, Roberts RM, Suda KJ, Hunkler RJ, Taylor TH Jr, et al. US outpatient antibiotic prescribing variation according to geography, patient population, and provider specialty in 2011. Clin Infect Dis. 2015;60:1308\u201316.","journal-title":"Clin Infect Dis"},{"key":"416_CR16","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.juro.2013.01.069","volume":"190","author":"RS Edlin","year":"2013","unstructured":"Edlin RS, Shapiro DJ, Hersh AL, Copp HL. Antibiotic resistance patterns of outpatient pediatric urinary tract infections. J Urol. 2013;190:222\u20137.","journal-title":"J Urol"},{"key":"416_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/2052-3211-7-10","volume":"7","author":"T Fukuda","year":"2014","unstructured":"Fukuda T, Watanabe H, Ido S, Shiragami M. Contribution of antimicrobial stewardship programs to reduction of antimicrobial therapy costs in community hospital with 429 beds\u2014before-after comparative two-year trial in Japan. J Pharm Policy Pract. 2014;7:10.","journal-title":"J Pharm Policy Pract"},{"key":"416_CR18","doi-asserted-by":"publisher","first-page":"158","DOI":"10.7883\/yoken.JJID.2017.330","volume":"71","author":"Y Ikeda","year":"2018","unstructured":"Ikeda Y, Shigemura K, Nomi M, Tabata C, Kitagawa K, Arakawa S, et al. Infection control following an outbreak of extended-spectrum bet alactamase-producing Klebsiella pneumoniae isolated from catheter-associated urinary tract infection. Jpn J Infect Dis. 2018;71:158\u201361.","journal-title":"Jpn J Infect Dis"},{"key":"416_CR19","doi-asserted-by":"crossref","unstructured":"Kinnear CL, Patel TS, Young CL, Marshall V, Newton DW, Read AF, et al. Impact of an antimicrobial stewardship intervention on within and between patient daptomycin resistance evolution in vancomycin-resistant Enterococcus faecium. Antimicrob Agents Chemother. 2019;63:e01800\u22128.","DOI":"10.1128\/AAC.01800-18"}],"container-title":["Spinal Cord"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41393-020-0416-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41393-020-0416-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41393-020-0416-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:38:54Z","timestamp":1684618734000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41393-020-0416-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,21]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["416"],"URL":"https:\/\/doi.org\/10.1038\/s41393-020-0416-8","relation":{},"ISSN":["1362-4393","1476-5624"],"issn-type":[{"type":"print","value":"1362-4393"},{"type":"electronic","value":"1476-5624"}],"subject":[],"published":{"date-parts":[[2020,1,21]]},"assertion":[{"value":"27 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"We certify that all applicable institutional and governmental regulations concerning the ethical use of human volunteers\/animals were followed during the course of this research.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}